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Abstract
Purpose To investigate the clinical outcome of two-stage
revision total hip arthroplasty for infected hip arthroplasty
using antibiotic-impregnated cement prosthesis.
Materials and methods Forty-one patients, who suffered
from an infection after hip replacement or internal fixation
of femoral neck and trochanteric fractures, were treated
with a two-stage revision hip arthroplasty and followed up
for an average of 37 months. All the patients were
implanted with antibiotic-impregnated cement prosthesis
as one-stage treatment and were then managed with two-
stage revision hip arthroplasty after 12–24 weeks. During
the follow-up, Merle d’Aubigne´ hip score and Harris score
were employed for assessment of hip function, and infec-
tion recurrence was observed.
Results According to Merle d’Aubigne´ hip score, 16
patients (39.2 %) were excellent, 19 (46.3 %) were good, 6
(14.6 %) were moderate, and no bad result and the average
score was 15.42. Mean Harris score of preoperation,
interval period, and postoperation was 46.7, 66.5, and 92.3,
respectively. There was no infection recurrence.
Conclusion Two-stage revision total hip arthroplasty for
infected hip arthroplasty using antibiotic-impregnated
cement prosthesis has a satisfying clinical outcome.
Keywords Infection  Antibiotic-impregnated cement
prosthesis  Revision total hip arthroplasty
Introduction
Hip infections include post-total hip replacement (THR)
infection, infection after internal fixation for femoral neck
and intertrochanteric fractures, and primary infection [1].
Postoperative infection is the most severe post-THR com-
plication. Although the incidence of postoperative infection
only ranges from 1 to 2 % [2], its disastrous consequences
do not only impose great pains and high medical costs on
patients, but become the difficulties as well as the bottle
neck in joint surgery.
Nowadays, surgical treatment methods for infected
hips mainly include debridement and prosthetic retention,
one-stage revision hip arthroplasty (the infected joint
prosthesis is taken out, and a new one is then implanted in
one operation), and two-stage revision hip arthroplasty
(the first operation is performed for foreign body removal
and thorough debridement, and the second is performed
for new prosthesis implantation after some time of
infection healing). For patients with obstinate repeated
infection or infection which poses life threat, hip fusion or
amputation may even be performed. With the successful
application of prostalac system in joint infection treat-
ment, two-stage revision hip arthroplasty has become the
gold standard in the treatment of post-THR infection.
Jackson and Schmalzried [3] analyzed retrospectively the
reports on one-stage revision hip arthroplasty before
2,000 and discovered that 1,077 of 1,229 hip infections
were well controlled with a success rate of 82.9 %.
Hanssen and Spangehl [4] reported that the infection
control rate of two-stage revision hip arthroplasty reached
90–100 %. Garvin and Hanssen [5] reported that the
success rate of one-stage revision hip arthroplasty for
1,189 patients with postoperative infection was 82 %,
whereas that of two-stage revision for 423 patients
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reached 91 %. Two-stage revision hip arthroplasty has an
obviously better effect on post-THR infection than one-
stage revision. In two-stage revision, the key steps lie in
thorough debridement, and the application of cement
spacer mixed with antibiotics. The temporary prosthesis
can create a local highly concentrated antibiotic envi-
ronment during the interval between the first and second
surgical procedures to effectively kill bacteria. This
ensures that the infection is well controlled on the one
hand and that the revision success rate is increased on
the other. Further, the temporary prosthesis can keep the
tension of soft tissues intact. Partial body weight-bearing
walking allowed during the interval between the first and
second operations can help patients maintain their affec-
ted hip function. Even though, Wentworth et al. [6]
reported that an infection recurrence rate between 10 and
15.1 % still occurs after one- or two-stage revision hip
arthroplasty involving the application of antibiotic-con-
taining bone cement. Therefore, there are still many
questions pertaining to the treatment of infected hips to be
solved.
The authors of the current study conducted long-term
explorations into how to increase the clinical recovery
rate of infected hips and improve patients’ hip function
and life quality and how to standardize the whole treat-
ment procedure. To achieve these goals, a temporarily
functional patent prosthetic die was developed for pros-
thetic creation using vancomycin (4 g)—containing bone
cement (80 g) which embraced a rigid structure of
Steinmann pin and steel wires. At the first stage, the
infected prosthesis was taken out, and a temporarily
functional prosthesis was implanted after thorough
debridement. All patients were allowed to walk with the
aid of crutches from 4 weeks after operation. At 12–24
weeks, when infection was completely controlled, they
were subjected to the second-stage revision hip arthro-
plasty. The involved 41 patients (41 hips) were followed
up for 37 months. Good results were obtained in infection
recovery rate and hip functional rehabilitation.
Materials and methods
Clinical data
This study was conducted in accordance with the Decla-
ration of Helsinki. This study was conducted with approval
from the Ethics Committee of Henan Provincial People’s
Hospital. Written informed consent was obtained from all
participants. Between March 2006 and June 2011, we
performed two-stage revision hip arthroplasty for a total of
41 patients with infected hip (41 hips). All of them had
Tsukayama type IV and late infection. The infected signs
were found from 3 months to 2 years after initial THA.
Among the patients, 28 were males and 13 were females
with an average age of 63.6 years (ranging from 51 to
76 years). All patients suffered from unilateral infection, in
which 24 were on the right side and 17 on the left side.
Their mean follow-up time was 37 months (ranging from
29 to 61 months) after revision.
Among the 41 infected hips, 2 occurred after dynamic
hip screw (DHS) internal fixation for femoral neck fracture,
1 occurred after compression hollow screw internal fixation
for femoral neck fracture, 1 occurred after proximal fem-
oral nail (PFN) internal fixation for femoral intertrochan-
teric fracture, and 34 occurred after THR. Seventeen had
sinus formation, 39 had hip persistent pain with continu-
ously increased erythrocyte sedimentation rate ([40 mm/h)
and C-reactive protein ([20 mg/L) as well as increased
white blood cell count and classification, 6 had positive
pre- or intra-operative secretions, and 12 had radiolucent
zones ([2 mm) around the prosthesis according to imaging
examination. Bone nuclide scanning showed that all the
infected hips displayed nuclide accumulations [7]; all the
hips were observed with obvious periosteal reactions
caused by infection: pub substances, inflammatory granu-
lation tissues, and reactive hyperosteogeny or worm-bitten-
like bone defects; and all frozen tissue sections presented a
white blood cell count of more than 10 (9400; 10 visual
fields) [8] (Fig. 1).
Fig. 1 a X-Ray films of THR postoperative infection. b Sinus formation postoperative infection. c Pub substances were observed during
operation
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Operative procedures
At the first stage, the infected prosthesis was dislocated and
taken out. Afterward, the false membranes between the
prosthesis and the bone surfaces [9], sinuses, inflammatory
granulation tissues, and bone cement were thoroughly
removed (particularly the bone cement, for that its remnant
is one of the primary causes for treatment failure [4]).
Pressurized hydrogen peroxide, metronidazole, and physi-
ologic saline solution irrigations were performed. Surface
sequestra were removed using an intramedullary broacher
and an acetabular reamer. For hip infection, after internal
fixation for femoral proximal fracture, femoral proximal
osteotomy used in THR was adopted after internal fixation
removal to take out the femoral head and neck, and then,
intramedullary broaching was performed but without
socket reaming (only infected tissues were cleared there).
The bone bed was washed using a sterilized brush and
pressed physiologic saline (no less than 3,000 ml). Then, a
self-developed standard temporary hip prosthetic die with a
fluted clamp on both sides was selected according to the
diameter of the femoral head (dies were divided into 44,
48, and 52 mm types according to different diameters)
(Fig. 2a). A rigid temporary prosthetic bone framework of
a Steinmann pin (2.5 mm in diameter) wound by steel
wires was placed in the die (Fig. 2b). Antibiotic-containing
bone cement curing liquid at 80 g (containing 4 g of
vancomycin) was stirred into wiredrawing and poured into
the die (Fig. 2c). After solidification, the created temporary
prosthesis was taken out (Fig. 2d). The prosthesis was
inserted into the femoral marrow cavity according to the
THR position, its anteversion angle was adjusted, and its
head was placed into the acetabulum (Fig. 3). The opera-
tive region was rinsed with physiologic saline, a drainage
tube was detained, and interrupted suturing was then
performed layer by layer. For hip infection after internal
fixation for femoral proximal fracture, the integrity of hip
muscles (especially those important dynamic muscles like
the middle gluteal muscle) was protected as much as pos-
sible since no previous excision had damaged them. The
drainage tube was extracted at 48 h after operation, anti-
biotics sensitive to bacteria were normally administrated
for 6 weeks (to those from which no bacteria were cultured,
intravenous administration of vancomycin (vancocin CP)
at 0.5 g was given twice a day), and then rifampicin was
orally administered for another 6 weeks [10]. Patients were
told to take partial body weight-bearing walks four times a
day from 4 weeks after operation, with each for approxi-
mately 50 m. The walking mainly focused on hip muscular
training (the training of the middle gluteal muscle in
particular).
The second operation was performed at 12–24 weeks
when ESR decreased below 20 mm/h, CRP decreased
below 20 mg/L [11], the wound healed well, and the
Fig. 2 a Standard temporary prosthesis mold designed by double-sided grooves gusset plate. b Steel skeleton implanted. c Pressure injection
molding by bone cement containing 5 % vancomycin. d Antibiotic bone cement temporary functional prosthesis
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patient had no pain in partial body weight-bearing condi-
tion. The operation was performed at the original incision
site. Fresh granulation tissues, clear cicatricial tissues, and
middle gluteal muscle in good elasticity were observed
around the temporary prosthesis. The prosthesis was taken
out, the surrounding granulation tissues were removed,
bone grafting was performed according to bone bed
defects, and a non-cemented total hip prosthesis was then
implanted.
Results
All the 41 infected hips healed with a recovery rate of
100 %. At 12 weeks after the first operation, the mean hip
functional score assessed by Merle d’Aubigne´’s method
was 13.2 with excellent, good, fair, and poor rates of 0,
41.1, 58.9, and 0 %, respectively. The mean Harris score
increased to 66.5 from preoperative 46.7. During the
interval between the first- and second-operative stages,
patients could walk in body weight-bearing condition with
the aid of crutches, and their life quality was greatly
improved. All the patients were followed up after the
second operation with an average follow-up time of
37 months. At the end of follow-ups, their mean Merle
d’Aubigne´ score increased to 15.42 with excellent, good,
fair, and poor rates of 39.2 % (16/41), 46.3 % (19/41),
14.6 % (6/41), and 0 % (0), respectively (the result was
based on the last follow-up for each patient). Their mean
Harris score increased to 92.3.
Discussion
To date, scholars have not found an efficient and systemic
treatment method in the treatment of hip infections. Once
such infections occur, they will cause serious hip joint
dysfunction or even lifelong disability even after healing.
The previously adopted implantation of antibiotic-loaded
cement beads and nonfunctional spacers into an infected
hip can neither meet the demands for patients’ walking and
hip functional protection during infection treatment period,
nor bring about a satisfactory recovery rate [12]. Even
worse, the implantation may lead to hip joint hypofunction
after second-stage revision hip arthroplasty due to muscu-
lar contracture and bone mass loss around the hip [13].
In the present study, a temporarily functional antibiotic-
loaded cement prosthesis was implanted after first-stage
debridement. This prosthesis can prolong the release time
of vancomycin in a great deal to form a long-term effective
bactericidal concentration in local tissues, which ensures
complete infection healing. The recovery rate in this study
was 100 %, and no recurrent infection was found according
to the 37 months’ follow-ups. The adoption of vancomycin
in this study was mainly based on its role as the first-line
antibiotic in the treatment of joint infections: It is resistant
to high temperature when mixed and solidified with bone
cement, is released slowly in local areas for long time, and
has a good curative effect on infections [14]. Vancomycin
has the following virtues: It can reach a peak concentration
rapidly in a local area to effectively kill bacteria and to
reduce the production of drug resistance bacteria; its direct
administration to a lesion site can avoid drug effect
reduction due to insufficient blood supply caused by
infection; further, only a small part of it can enter into the
whole body blood circulation, which only results in slight
toxic effects on important organs [15]. More than 50 % of
the pathogenic bacteria responsible for post-THR infec-
tions are gram-positive cocci, on which vancomycin has
the best effect among different antibiotics [16]. Bone
cement mixed with 5 % vancomycin does not have obvi-
ously reduced mechanical strength as compared to cement
alone, which, thus, can guarantee weight-bearing walking
during treatment. On the other hand, the loaded vanco-
mycin can be released gradually around the hip joint,
performing a good long-term bacterium-killing effect. The
present study did not show that vancomycin caused any
damage to liver and kidney function.
The placement of a rigid framework into the temporarily
functional prosthesis can ensure that the prosthesis possesses
sufficient weight-bearing strength. This placement enables
patients to walk with the aid of crutches, effectively protects
Fig. 3 a Insertion prosthesis into femoral medullary canal. b Restoration of Antibiotic bone cement temporary functional prosthesis. c X-ray
after implantation
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the muscles and soft tissues around the hip joint and main-
tains good tensions of and blood supplies for the muscular
tissues around the hip. Meanwhile, it prevents bone loss
due to prolonged bed rest and enhances the anti-infection
capacity of local tissues. In the present study, the mean
Harris score was 46.7 before debridement, which increased
to 66.5 during the operative interval and then to 92.3 after
the second operation. Both of these scores were better than
that reported in another study involving the application of
prostalac system [17]. Patients in this study could walk
during the whole treatment period, and their life quality was
greatly improved. No prosthetic fracture occurred during the
treatment period. In addition, although antibiotic-loaded
cement prosthesis on the acetabular side was not used in this
study, the results did not show walking pain among the
patients or a reduced infection recovery rate of them.
The infected hip treatment system in this study is made
using a patent die (Chinese utility patent no.: 1072294) and
5 % vancomycin-containing bone cement. The whole making
process is simple and highly repeatable. A proper prosthesis
can be made according to the sizes of the femoral marrow
cavity and acetabulum during operation. Compared to the
prostalac system [18], this system is simpler in use and much
lower in treatment costs, and meanwhile better improves
patients’ life quality, brings about a higher Harris score, and
increases infection recovery rate. In this study, the interval
between the first and second operations was prolonged to
12–24 weeks rather than the conventional 6–12 weeks. This
prolongation was out of the following considerations: (1)
There is still an infection recurrence rate between 10 and
15.1 % after one- or two-stage antibiotic-containing revision
hip arthroplasty (6); (2) 5 % vancomycin in bone cement is
still at an effective bacterium-killing concentration in local
areas at 24 weeks; and; (3) antibiotics in temporary prosthesis
can work for more than 4 months in vivo [19].
The consequences of infected hips are disastrous, and
their treatment has become the difficulty in joint surgery.
Although the successful application of prostalac system has
given great encouragement and inspiration to scholars, its
complicated manufacturing process and high treatment
costs force them to develop systems which are simpler in
use, lower in cost, better in hip functional protection, and
higher in infection recovery rate. In the present study, we
used self-developed temporarily functional antibiotic-
containing cement prosthesis, whose clinical value for
infected hips is initially confirmed.
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